cp wire

CP Wire Articles

Galapagos Announces ISABELA Ph III Study in Idiopathic Pulmonary Fibrosis



  • GLPG1690 has orphan drug status in US and Europe
  • Ph II results showed disease stabilization over 12 week period
  • ISABELA intended to support NDA and MAA in... read more
Thu, 04/12/18 - 08:26 pm
Wistar Researchers Find Combination Therapy Effective for NRAS Mutant and Therapy Resistant Melanoma

Wistar researchers have identified a novel therapeutic vulnerability in NRAS mutant melanoma and an effective strategy to address it, using a combination of two clinically relevant inhibitors,... read more

Thu, 04/12/18 - 11:56 am
Pfizer Commences Ph Ib Trial With Mini-Dystrophin Gene Therapy for the Treatment of Duchenne Muscular Dystrophy




  • The clinical candidate, PF-06939926, consists of a recombinant AAV  Glossary Link vector expressing a miniaturized version of the DMD gene, which encodes the domains... read more
Thu, 04/12/18 - 09:22 am
Enterprise Therapeutics Raises $41 Million Series B Funding To Develop Muco-Regulatory Pipeline

  • Raises Series B round co-led by Versant Ventures and Novartis Venture Fund, with Forbion, Epidarex... read more

Thu, 04/12/18 - 08:45 am
Bellicum Shares Up After Clinical Hold lifted on BPX-501

Bellicum today announced that the U.S. Food and Drug Administration has lifted the clinical hold on studies of BPX-501 in the U.S. The decision follows consultation with the FDA and agreement on... read more

Wed, 04/11/18 - 10:32 pm

Pages